Pay in 4 interest-free payments of $5.82 Learn more
Ships within 48 hours · Estimated delivery Oct 4 - Oct 9
Despite the companys claim that their product supports healthy appetite control, weight management, and GLP-1 production, there is no reliable scientific evidence demonstrating that these claims are true
J Neurosci Res (2011) 89(4):4819
In an industrial project in development, Cardiol Therapeutics has developed a polymeric micellar formulation of CBD (CTX 01) for subcutaneous administration
Explore Restores GLP-1 Plans and start your personalized journey today
GLP-1 receptors modulate incretin signaling and gastric motility
Clinical trials lasting 68 weeks and longer show that people who continue treatment are more likely to achieve and sustain meaningful weight loss compared to those who stop therapy
US$ 21.75
US$ 22.42
US$ 20.71
US$ 29.77
US$ 24.52
US$ 29.88
